Blockchain Registration Transaction Record

Viromed Gains ISO 13485 Certification, Launches ViroCAP® Devices in October

Viromed Medical AG receives ISO 13485 certification, enabling market launch of ViroCAP® cold plasma devices for dermatology and wound care in October 2025.

This development matters because it introduces innovative, non-invasive medical technology that could transform treatment for skin diseases and wounds, offering patients safer, contact-free options with reduced infection risks. For the healthcare industry, Viromed's certification and product launch signal advancements in cold plasma applications, potentially leading to more efficient and accessible treatments. Investors and stakeholders may benefit from the company's growth potential and competitive edge in emerging medical markets.